On February 17, 2025, XRHealth acquired RealizedCare, creating the largest AI-driven XR platform. This merger positions XRHealth as a leader in immersive, value-based healthcare solutions.
Platform Scale and Impact
The acquisition marks a significant milestone in digital therapeutics, with XRHealth’s platform now supporting over 2,000 clinicians treating more than 50,000 patients and facilitating over 1 million XR therapy sessions globally [1]. This integration comes at a crucial time as the metaverse healthcare sector experiences unprecedented growth, with the global metaverse market valued at USD 105.40 billion in 2024 and projected to grow at a CAGR of 46.4% from 2025 to 2030 [4].
Strategic Partnerships and Innovation
RealizedCare brings impressive credentials to the merger, having developed its solutions in collaboration with prestigious institutions including Oxford University, Massachusetts General Hospital, Sumitomo Pharma, and Confluent Health [1]. A key feature of RealizedCare’s technology is its AI triage tool, which intelligently guides patients to appropriate interventions and escalates cases to clinicians when necessary [1].
Leadership Vision
Eran Orr, CEO of XRHealth, emphasizes the transformative nature of this acquisition: ‘By merging the power of mixed reality, extended reality, and AI-driven insights, we are forging a new era of immersive, value-based care’ [1]. This sentiment is echoed by Aaron Gani, Founder & CEO of RealizedCare, who expressed enthusiasm about joining XRHealth’s groundbreaking digital therapeutics platform [1].
Future Implications
This strategic move aligns with broader industry trends, as major corporations increasingly invest in virtual healthcare solutions [4]. The acquisition builds upon XRHealth’s previous strategic moves, including their acquisition of NeuroReality in September 2024 [1]. The company is actively demonstrating its expanded capabilities, showcasing its latest solutions at ViVE in Nashville, TN, from February 16-19, 2025 [1][5].